Back to Search
HO

Hologic

Healthcare
PE-OWNED

PE-OWNED

Acquired by Unknown PE Firm

View PE Firm Profile

What PE Will Likely Do

Hologic's diagnostic imaging equipment (e.g. mammography, bone density scanners, breast ultrasound) will likely experience quality degradation as the PE firms cut costs. This could include using cheaper components, reducing maintenance and calibration standards, and deferring equipment upgrades.

HIGH LIKELIHOODBased on: The PE firms involved (TPG and Blackstone) have a track record of cost-cutting and quality reduction in their acquisitions, with a focus on maximizing returns for investors rather than maintaining high product/service standards.

The company's surgical and medical devices, such as their minimally invasive surgical systems, may see a decline in quality and reliability as the PE firms push for cost savings. This could manifest in more device malfunctions, shortened product lifespans, and reduced R&D investment.

HIGH LIKELIHOODBased on: The healthcare industry playbook indicates that common PE tactics in this sector include staffing reductions, billing upcoding, and service line cuts - all of which are likely to degrade the quality of Hologic's products and services.

Hologic's women's health products, including their cervical cancer screening tests and prenatal diagnostics, may suffer from reduced innovation, narrowed product portfolios, and cost-cutting that impacts test accuracy or reliability.

HIGH LIKELIHOODBased on: The timeline of changes is based on typical patterns observed in other PE-acquired healthcare companies, where initial 'optimization' leads to gradual quality decline and eventually major issues for customers.

Expected Timeline

0-6 monthsCompleted

0 to 6 months months

Announcement of 'optimization' initiatives and leadership changes at Hologic, with promises of improving 'efficiency'

6-12 monthsYOU ARE HERE

6 to 12 months months

Gradual staffing reductions in R&D, service, and support roles, leading to delayed product upgrades and longer customer wait times

12-24 months

12 to 24 months months

Noticeable decline in product quality and reliability as maintenance is deferred and cheaper components are used. Customers report more equipment breakdowns, delays in getting repairs, and reduced confidence in test results.

24-36 months

24 to 36 months months

Major quality issues emerge, with reports of inaccurate diagnoses, device malfunctions during procedures, and potentially life-threatening complications for patients. Regulatory scrutiny and lawsuits may follow.

Similar Cases

Other companies that followed a similar path after PE acquisition

What You Can Do

Actions

  • Consumers should be vigilant about any changes to their medical devices or diagnostic tests from Hologic, and report any quality issues or concerns to the company and relevant regulatory bodies.

  • Patients receiving care or procedures involving Hologic equipment should ask their providers about the maintenance and calibration schedules, and advocate for the use of the latest generation of devices.

  • Healthcare providers should closely monitor the performance and reliability of Hologic products, and be prepared to seek alternative suppliers if quality issues emerge.

Alternatives

Non-profit health systemsSAFE

Community-focused healthcare

Kaiser PermanenteSAFE

Integrated managed care consortium

Share this company's PE status

"Hologic is now PE-owned. Here's what that means for you."